A case of acute basilar artery occlusion due to atherosclerotic disease revascularized by drug-coated balloon dilation

References

• Lindsberg PJ, Pekkola J, Strbian D, et al. Time window for recanalization in basilar artery occlusion: speculative synthesis. Neurology. 2015;85(20):1806–1815. Nov 17eng Cited in: pubmed; PMID 26574535.
   PubMed Web of Science ®Google Scholar
• Mak CH, Ho JW, Chan KY, et al. Intra-arterial revascularization therapy for basilar artery occlusion-a systematic review and analysis. Neurosurg Rev. 2016;39(4):575–580. OctengEpub 20160125 Cited in: pubmed; PMID 26810313.
   PubMed Web of Science ®Google Scholar
• Gory B, Eldesouky I, Sivan-Hoffmann R, et al. Outcomes of stent retriever thrombectomy in basilar artery occlusion: an observational study and systematic review. J Neurol Neurosurg Psychiatry. 2016; May87(5):520–525. engEpub 20150518 Cited in: pubmed; PMID 25986363.
   PubMed Web of Science ®Google Scholar
• Le TM, Gaughen JR, Jensen ME, et al. Symptomatic wingspan stent stenosis and occlusion: stent-in-stent rescue. J Neurointerv Surg. 2010;2(4):348–350. DecengEpub 20100604 Cited in: pubmed; PMID 21990644.
   PubMed Web of Science ®Google Scholar
• Jovin TG, Li C, Wu L, et al. Trial of thrombectomy 6 to 24 hours after stroke due to Basilar-Artery occlusion. N Engl J Med. 2022;387(15):1373–1384. Oct 13eng. Cited in: pubmed; PMID 36239645.
   PubMed Web of Science ®Google Scholar
• Tao C, Nogueira RG, Zhu Y, et al. Trial of endovascular treatment of acute Basilar-Artery occlusion. N Engl J Med. 2022;387(15):1361–1372. Oct 13eng. Cited in: pubmed; PMID 36239644.
   PubMed Web of Science ®Google Scholar
• Chen WH, Yi TY, Zhan AL, et al. Stent-unsheathed effect predicts acute distal Middle cerebral artery atherosclerotic disease-related occlusion. J Neurol Sci. 2020;416:116957. 2020 Sep 15 eng. Epub 20200607. Cited in: pubmed; PMID 32535360.
   PubMed Web of Science ®Google Scholar
• Yi TY, Chen WH, Wu YM, et al. Microcatheter "First-Pass effect" predicts acute intracranial artery atherosclerotic Disease-Related occlusion. Neurosurgery. 2019;84(6):1296–1305. Jun 1eng Cited in: pubmed; PMID 29790969.
   PubMed Web of Science ®Google Scholar
• Liu Z, Liebeskind DS. Basilar artery occlusion and emerging treatments. Semin Neurol. 2021; Feb41(1):39–45. engNoneEpub 20210114 Cited in: pubmed; PMID 33469899.
   PubMed Web of Science ®Google Scholar
• Chandwar K, Shah C. Trial of endovascular treatment of Basilar-Artery occlusion. N Engl J Med. 2021; Sep 2385(10):959. eng. Cited in: pubmed; PMID 34469659.
   PubMedGoogle Scholar
• Ang H, Koppara TR, Cassese S, et al. Drug-coated balloons: technical and clinical progress. Vasc Med. 2020;25(6):577–587. Deceng. Epub 20200707. Cited in: pubmed; PMID 32634046.
   PubMed Web of Science ®Google Scholar
• Remonda L, Diepers M, Berberat J, et al. Drug-Coated balloon treatment in symptomatic intracranial high grade stenosis: a retrospective study of 33 patients. Clin Neuroradiol. 2021;31(1):45–49. MarengEpub 20200720 Cited in: pubmed; PMID 32691077.
   PubMed Web of Science ®Google Scholar
• Han J, Zhang J, Zhang X, et al. Drug-coated balloons for the treatment of symptomatic intracranial atherosclerosis: initial experience and follow-up outcome. J Neurointerv Surg. 2019; Jun11(6):569–573. engCompeting interestsNone declared. Epub 20181018. Cited in: pubmed; PMID 30337378.
   PubMed Web of Science ®Google Scholar
• Yin H, Zhang J, Zhao W, et al. Drug-Coated balloon for the treatment of nonacute symptomatic intracranial carotid artery terminus occlusion: initial experience and Follow-Up outcome. Front Neurol. 2022;13:840865. engThe authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. Epub 20220211. Cited in: pubmed; PMID 35222260.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Chu X, Meng Y, et al. Drug-Coated Balloon-Oriented angioplasty for severe symptomatic atherosclerotic MCA stenosis in young adults. Front Neurol. 2021;12:743851. engThe authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. Epub 20220201. Cited in: pubmed; PMID 35178020.
   PubMed Web of Science ®Google Scholar
• Sella G, Gandelman G, Tuvali O, et al. Utilization of Drug-Coated balloons for the treatment of coronary lesions in the elderly population. JCM. 2022;11(9):2616. May 6engThe authors declare no conflict of interestEpub 20220506. Cited in: pubmed; PMID 35566739.
   Web of Science ®Google Scholar
• Zhang Y, Zhang X, Dong Q, et al. Duration of dual antiplatelet therapy after implantation of Drug-Coated balloon. Front Cardiovasc Med. 2021;8:762391. eng. The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. Epub 20211201. Cited in: pubmed; PMID 34926613.
   PubMed Web of Science ®Google Scholar
• Cremers B, Speck U, Kaufels N, et al. Drug-eluting balloon: very short-term exposure and overlapping. Thromb Haemost. 2009;101(1):201–206. Janeng. Cited in: pubmed; PMID 19132209.
   PubMed Web of Science ®Google Scholar
• Pósa A, Nyolczas N, Hemetsberger R, et al. Optimization of drug-eluting balloon use for safety and efficacy: evaluation of the 2nd generation paclitaxel-eluting DIOR-balloon in porcine coronary arteries. Catheter Cardiovasc Interv. 2010;76(3):395–403. Sep 1eng Cited in: pubmed; PMID 20839356.
   PubMed Web of Science ®Google Scholar
• Maranhão RC, Tavares ER. Advances in non-invasive drug delivery for atherosclerotic heart disease. Expert Opin Drug Deliv. 2015; Jul12(7):1135–1147. engEpub 20150114 Cited in: pubmed; PMID 25585820.
   PubMed Web of Science ®Google Scholar
• Gruber P, Braun C, Kahles T, et al. Percutaneous transluminal angioplasty using the novel drug-coated balloon catheter SeQuent please NEO for the treatment of symptomatic intracranial severe stenosis: feasibility and safety study. J Neurointerv Surg. 2019;11(7):719–722. JulengCompeting interestsNone declared. Epub 20181110. Cited in: pubmed; PMID 30415229.
   PubMed Web of Science ®Google Scholar
• Stapleton CJ, Chen YF, Shallwani H, et al. Submaximal angioplasty for symptomatic intracranial atherosclerotic disease: a Meta-Analysis of Peri-Procedural and Long-Term risk. Neurosurgery. 2020;86(6):755–762. Jun 1eng Cited in: pubmed; PMID 31435656.
   PubMed Web of Science ®Google Scholar
• Zhao W, Chu X, Song Y, et al. Drug-Coated balloon treatment for delayed recanalization of symptomatic intracranial artery occlusion. Transl Stroke Res. 2023;14(2):193–199. Apr 23. engEpub 20220423 Cited in: pubmed; PMID 35460456.
   PubMed Web of Science ®Google Scholar